• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BOSTON SCIENTIFIC CORPORATION RANGER; CATHETER, PERCUTANEOUS

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BOSTON SCIENTIFIC CORPORATION RANGER; CATHETER, PERCUTANEOUS Back to Search Results
Model Number 1177-01
Device Problem Use of Device Problem (1670)
Patient Problem Foreign Body In Patient (2687)
Event Date 03/23/2022
Event Type  Injury  
Manufacturer Narrative
Lot number of the other used ranger drug-coated balloon, that the protective sleeve could have come from: 06451h21.
 
Event Description
It was reported that surgical intervention was required to remove an unretrieved device fragment.A 6x60 ranger drug-coated balloon and 6x80cm ranger drug-coated balloon were selected for use during a procedure on (b)(6) 2022.A percutaneous transluminal angioplasty (pta) procedure was performed in the right thigh.On (b)(6) 2022, the same procedure was required to be performed again due to complaints in the same leg.The intervention was unsuccessful.A femoral-crucal bypass was performed on the same day.While the p3 segment was exposed during an arteriotomy, the 13cm protective sleeve of a ranger balloon was found inside the patient, which was then explanted.The patient fully recovered.The procedure was completed.
 
Manufacturer Narrative
D4.Lot number: reported as 06451h21 or 01895h21.
 
Event Description
It was reported that surgical intervention was required to remove an unretrieved device fragment.A 6x60 ranger drug-coated balloon and 6x80cm ranger drug-coated balloon were selected for use during a procedure on (b)(6) 2022.A percutaneous transluminal angioplasty (pta) procedure was performed in the right thigh.On (b)(6) 2022, the same procedure was required to be performed again due to complaints in the same leg.The intervention was unsuccessful.A femoral-crucal bypass was performed on the same day.While the p3 segment was exposed during an arteriotomy, the 13cm protective sleeve of a ranger balloon was found inside the patient, which was then explanted.The patient fully recovered.The procedure was completed.It was further reported that the loading tool was left inside the patient.After the balloon had been used, an x-ray at the highest magnification was performed but it could not find the loading tool.The procedure performed on (b)(6) 2022 was to treat the sfa as it had become occluded again after four weeks.An arteriotomy had already been planned before the loading tool was found inside the patient.
 
Event Description
It was reported that surgical intervention was required to remove an unretrieved device fragment.A 6x60 ranger drug-coated balloon and 6x80cm ranger drug-coated balloon were selected for use during a procedure on (b)(6) 2022.A percutaneous transluminal angioplasty (pta) procedure was performed in the right thigh.On (b)(6) 2022, the same procedure was required to be performed again due to complaints in the same leg.The intervention was unsuccessful.A femoral-crucal bypass was performed on the same day.While the p3 segment was exposed during an arteriotomy, the 13cm protective sleeve of a ranger balloon was found inside the patient, which was then explanted.The patient fully recovered.The procedure was completed.It was further reported that the loading tool was left inside the patient.After the balloon had been used, an x-ray at the highest magnification was performed but it could not find the loading tool.The procedure performed on (b)(6) was to treat the sfa as it had become occluded again after four weeks.An arteriotomy had already been planned before the loading tool was found inside the patient.
 
Manufacturer Narrative
D4.Lot number: reported as 06451h21 or 01895h21.Device eval by mfr: the ranger was not received for analysis but the loading tool was received.Visual and microscopic analysis was completed.The device showed signs of use with some blood matter seen in the kinks.The device was 13 cm in length.It was round and hollow.Kinks were confirmed at 1.3 cm, 7.4 cm, 8.7 cm, and 11.1 cm, across the device.The account supplied pictures of what was explanted from the patient and the device received closely resembles the image in the pictures.The complaint was confirmed.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
RANGER
Type of Device
CATHETER, PERCUTANEOUS
Manufacturer (Section D)
BOSTON SCIENTIFIC CORPORATION
two scimed place
maple grove MN 55311
Manufacturer (Section G)
HEMOTEQ AG
adenauerstrasse 15
wuerselen 52146
GM   52146
Manufacturer Contact
jay johnson
4100 hamline ave n
arden hills, MN 55112
6515810888
MDR Report Key14580253
MDR Text Key293253303
Report Number2134265-2022-05897
Device Sequence Number1
Product Code ONU
Combination Product (y/n)Y
Reporter Country CodeGM
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,Health Professional,Company Representative
Reporter Occupation Physician
Type of Report Initial,Followup,Followup
Report Date 08/19/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received06/02/2022
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date03/09/2023
Device Model Number1177-01
Device Catalogue Number1177-01
Device Lot Number01895H21
Was Device Available for Evaluation? Device Returned to Manufacturer
Is the Reporter a Health Professional? Yes
Date Manufacturer Received08/04/2022
Was Device Evaluated by Manufacturer? Yes
Date Device Manufactured03/09/2021
Is the Device Single Use? Yes
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient SexMale
-
-